Thiamine Dosing in Wernicke Encephalopathy

Acute Treatment (Suspected or Confirmed WE)

Key Dosing Points by Source

• Harrison's (2025): "500 mg IV - begun prior to IV glucose, three times daily for 2-3 days. Thiamine may then be given in smaller maintenance doses." - Harrison's Principles of Internal Medicine 22E
• Adams & Victor's Neurology (12th ed): Confirms initial doses of 500 mg IV to fully reverse manifestations, followed by 50-200 mg IV/IM daily until normal diet resumes.
• Maudsley Prescribing Guidelines (15th ed): 200-300 mg IV/IM once daily for 3-5 days for prophylaxis/at-risk patients; if WE is confirmed, transfers to medical unit for high-dose IV therapy.
• Kaplan & Sadock: 500 mg IV two to three times daily for 3-5 days for confirmed WE.

Critical Principles

1. Treat before glucose - Giving IV dextrose before thiamine can precipitate or worsen WE in thiamine-deficient patients by further depleting already-marginal thiamine stores. Always give thiamine first.
2. Do not wait for confirmation - WE is underdiagnosed (estimated in ~2% of general population, much higher in alcohol use disorder). Treat empirically if clinically suspected. Symptoms include the classic triad: ophthalmoplegia, ataxia, and confusion (all three present in only ~10-16% of cases).
3. Correct magnesium - Magnesium is required for thiamine activation (as a cofactor for thiamine-dependent enzymes). Hypomagnesemia (common in alcoholism) can blunt the response to thiamine supplementation.
4. Prophylaxis in at-risk patients: For patients at high risk (alcohol use disorder, malnutrition, significant weight loss, low BMI) without active WE: 200-300 mg IV/IM once daily for 3-5 days.

Prognosis by Symptom

Recent Evidence (Systematic Review, 2024)

• 500 mg IV TID was the most reported dose across case reports (60% of cases)
• 90% of case reports showed partial or complete symptom resolution with IV thiamine
• IV thiamine is underutilized despite being the standard of care
• Evidence is limited by lack of RCTs; current practice is largely expert-consensus and case-series based

IV KCl Correction: Rate and Concentration

Summary Table

Rate by Serum Potassium Level

Key Rules

• Peripheral max is 40 mEq/L - solutions >30 mEq/L already cause pain and phlebitis; extravasation causes serious chemical burns
• Central lines tolerate 150-200 mEq/L due to high blood flow dilution; the highest commercial concentrations (400 mEq/L) are central-only
• Never give KCl undiluted IV (can cause fatal cardiac arrest)

• Morgan & Mikhail's Clinical Anesthesiology: peripheral should not exceed 8 mEq/hr (conservative surgical standard); central 10-20 mEq/hr with ECG monitoring
• Tintinalli's Emergency Medicine: 10 mEq/hr peripheral, 20 mEq/hr central as general standard
• Mulholland's Surgery: peripheral 10-20 mEq/hr, central up to 40 mEq/hr
• Harriet Lane (adults): K ≥2.5 → up to 10 mEq/hr; K <2.5 → up to 40 mEq/hr (central)

• Required for infusions >0.5 mEq/kg/hr (>20 mEq/hr in adults)
• Watch for: peaked T waves, QRS widening >25% baseline, ST depression, disappearance of P waves, prolonged QT

• Each 20 mEq IV KCl raises serum K+ by approximately ~0.25 mEq/L
• Potassium is predominantly intracellular - serum levels underestimate total body deficit significantly

Special Considerations

• Avoid dextrose-containing solutions - glucose triggers insulin release, which drives K+ intracellularly and worsens hypokalemia
• Check and correct magnesium first - hypomagnesemia causes refractory hypokalemia (Mg is required for renal K+ reabsorption). Repletion of K+ will fail without correcting co-existing Mg deficiency
• Salt selection: KCl is preferred when metabolic alkalosis is also present (corrects chloride deficit simultaneously); K-bicarbonate/acetate/citrate for metabolic acidosis; K-phosphate for DKA with hypophosphatemia
• Oral route is always preferred when the patient can tolerate it (safer, avoids arrhythmia risk)